Localized Interleukin-12 for Cancer Immunotherapy

Interleukin-12 (IL-12) is a potent, pro-inflammatory type 1 cytokine that has long been studied as a potential immunotherapy for cancer. Unfortunately, IL-12's remarkable antitumor efficacy in preclinical models has yet to be replicated in humans. Early clinical trials in the mid-1990's sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Khue G., Vrabel, Maura R., Mantooth, Siena M., Hopkins, Jared J., Wagner, Ethan S., Gabaldon, Taylor A., Zaharoff, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593768/
https://www.ncbi.nlm.nih.gov/pubmed/33178203
http://dx.doi.org/10.3389/fimmu.2020.575597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593768/
https://www.ncbi.nlm.nih.gov/pubmed/33178203
http://dx.doi.org/10.3389/fimmu.2020.575597

Ejemplares similares